Kristina Boye, Associate Vice President, Value, Evidence, and Outcomes, Eli Lilly and Company
Advertisement
Articles by Kristina Boye, Associate Vice President, Value, Evidence, and Outcomes, Eli Lilly and Company
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes
2
Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Study
3
New Liver Cancer BEACON-HCC Framework Shows 96.6% Concordance in Pilot
4
After Sickle Cell Gene Therapy, What Comes Next?
5